{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:05:33Z","timestamp":1764785133594},"reference-count":28,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDRR"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Mucormycosis has been infesting the universe for a while back, often\nwith no prompt treatments. The disease devastation is spreading at an alarming rate. Many researchers\nare still hoping for a good potential drug that could help the healthcare system in this\ntussle. Molecular docking is an in silico tool that has gained popularity over the last few decades.\nKnowing the mechanism of enzymatic action is aided by imitating membrane protein actions in\nbinding ligands.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Aim:<\/jats:title>\n<jats:p>The aim of this perspective is to determine whether an existing drug, daclatasvir, has antifungal\nactivity.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The primary objective of this in silico study was to investigate the potential effects of\nthe binding affinity of daclatasvir with the crucial protein (1XFF) of mucormycosis, as well as the\nbinding pattern of the active site amino acids with the drug molecule.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Materials and Methods:<\/jats:title>\n<jats:p>To calculate the binding affinity of daclatasvir to the fungal protein\n1XFF, Auto Dock Vina was used for molecular docking studies. The CDOCKER protocol was\nused to determine the receptor-ligand interaction by configuring various parameters.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The docking energy of the ligand (daclatasvir) on the protein (1XFF) was found to be -\n16.7216 kcal\/mol, while the interaction energy was found to be -42.1314 kcal\/mol.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The binding pattern completely alters the dynamics of the protein, resulting in the\nbreakdown of the fungal wall. The vital protein (1XFF) of Rhizopus oryzae is proposed as a possible\nprotein target for the non-structural protein 5A inhibitor\/antiviral drug daclatasvir in this\nstudy.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/2589977515666230430004013","type":"journal-article","created":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T06:00:16Z","timestamp":1682920816000},"page":"5-10","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Is Daclatasvir a Suitable Substitute for Amphotericin B in the Treatment\nof Mucormycosis when Amphotericin B is Scarce?"],"prefix":"10.2174","volume":"16","author":[{"given":"Pugazhenthan","family":"Thangaraju","sequence":"first","affiliation":[{"name":"Department of Pharmacology, All India Institute of Medical Sciences, Raipur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sree Sudha","family":"Tanguturi Yella","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, All India Institute of Medical Sciences, Deoghar, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijayakumar","family":"Arumugam Ramamurthy","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Pharmacy, Sree Balaji Medical College and Hospital, Biher, Chennai, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sivakumar","family":"Muthusamy","sequence":"additional","affiliation":[{"name":"Departments of Pharmacognosy, Faculty of Pharmacy, Sree Balaji Medical College and Hospital, Biher, Chennai, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lappathai Habib","family":"Mohamed Thameemul Ansari","sequence":"additional","affiliation":[{"name":"Crescent School of Pharmacy, B.S. Abdur Rahman\nCrescent Institute of Science &amp; Technology, Vandalur, Chennai, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irfan","family":"Navabshan","sequence":"additional","affiliation":[{"name":"Crescent School of Pharmacy, B.S. Abdur Rahman\nCrescent Institute of Science &amp; Technology, Vandalur, Chennai, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajitha","family":"Venkatesan","sequence":"additional","affiliation":[{"name":"Department of Microbiology, All India Institute of Medical Sciences, Raipur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1128\/CMR.13.2.236","volume":"13","author":"Ribes J.A.","year":"2000","unstructured":"Ribes J.A.; Vanover-Sams C.L.; Baker D.J.; Zygomycetes in human disease. Clin Microbiol Rev 2000,13(2),236-301","journal-title":"Clin Microbiol Rev"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1128\/CMR.18.3.556-569.2005","volume":"18","author":"Spellberg B.","year":"2005","unstructured":"Spellberg B.; Edwards J.; Ibrahim A.; Novel perspectives on mucormycosis: Pathophysiology, presentation, and management. Clin Microbiol Rev 2005,18(3),556-569","journal-title":"Clin Microbiol Rev"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/432579","volume":"41","author":"Roden M.M.","year":"2005","unstructured":"Roden M.M.; Zaoutis T.E.; Buchanan W.L.; Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clin Infect Dis 2005,41(5),634-653","journal-title":"Clin Infect Dis"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1080\/10428190310001653691","volume":"45","author":"Gleissner B.","year":"2004","unstructured":"Gleissner B.; Schilling A.; Anagnostopolous I.; Siehl I.; Thiel E.; Improved outcome of zygomycosis in patients with hematological diseases? Leuk Lymphoma 2004,45(7),1351-1360","journal-title":"Leuk Lymphoma"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"703","DOI":"10.4103\/ijo.IJO_843_20","volume":"68","author":"Khanna R.","year":"2020","unstructured":"Khanna R.; Cicinelli M.; Gilbert S.; Honavar S.; Murthy G.V.; COVID-19 pandemic: Lessons learned and future directions. Indian J Ophthalmol 2020,68(5),703-710","journal-title":"Indian J Ophthalmol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1889e94","DOI":"10.1016\/j.dsx.2020.09.022","volume":"14","author":"Unnikrishnan R","year":"2020","unstructured":"Unnikrishnan R; Misra A.; Infections and diabetes: Risks and mitigation with reference to India. Diabet Metabol Syndr 2020,14(6),1889e94","journal-title":"Diabet Metabol Syndr"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"289e98","DOI":"10.1007\/s11046-021-00528-2","volume":"186","author":"Garg D.","year":"2021","unstructured":"Garg D.; Coronavirus disease (Covid-19) Associated Mucormycosis (CAM): Case report and systematic review of literature. Mycopathologia 2021,186(2),289e98","journal-title":"Mycopathologia"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"1e8","DOI":"10.1007\/s12663-021-01604-2","volume":"20","author":"Jose A.","year":"2021","unstructured":"Jose A.; Current understanding in the pathophysiology of SARSCoV-2- associated rhino-orbito-cerebral mucormycosis: A comprehensive review. J Maxillofacial Oral Surg 2021,20(3),1e8","journal-title":"J Maxillofacial Oral Surg"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"e01087","DOI":"10.1128\/mBio.01087-20","volume":"11","author":"Alqarihi A.","year":"2020","unstructured":"Alqarihi A.; Gebremariam T.; Gu Y.; GRP78 and integrins play different roles in host cell invasion during mucormycosis. MBio 2020,11(3),e01087-e20","journal-title":"MBio"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"102148","DOI":"10.1016\/j.tmaid.2021.102148","volume":"44","author":"Dilek A.","year":"2021","unstructured":"Dilek A.; Ozaras R.; Ozkaya S.; Sunbul M.; Sen E.I.; Leblebicioglu H.; COVID-19-associated mucormycosis: Case report and systematic review. Travel Med Infect Dis 2021,44,102148-8","journal-title":"Travel Med Infect Dis"},{"key":"ref=11","first-page":"2349e59","volume":"27","author":"Patel A","year":"2021","unstructured":"Patel A; Agarwal R; Rudramurthy SM; Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India. Emerg Infect Dis 2021,27(9),2349e59","journal-title":"Emerg Infect Dis"},{"key":"ref=12","first-page":"1670e92","volume":"69","author":"Sen M","year":"2021","unstructured":"Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Members of the Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC) study group. Epidemiology, clinical profile, management, and outcome of COVID-19- associated rhino-orbitalcerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), report 1. Indian J Ophthalmol 2021,69(7),1670e92","journal-title":"Indian J Ophthalmol"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1017\/S0022215121000992","volume":"1-135","author":"Sharma S","year":"2021","unstructured":"Sharma S; Grover M; Bhargava S; Samdani S; Kataria T; Post coronavirus disease mucormycosis: A deadly addition to the pandemic spectrum. J Laryngol 2021,1-135(5),442-7","journal-title":"J Laryngol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.idc.2015.10.011","volume":"30","author":"Farmakiotis D.","year":"2016","unstructured":"Farmakiotis D.; Kontoyiannis D.P.; Mucormycoses. Infect Dis Clin North Am 2016,30(1),143-163","journal-title":"Infect Dis Clin North Am"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.idc.2021.03.009","volume":"35","author":"Steinbrink J.M.","year":"2021","unstructured":"Steinbrink J.M.; Miceli M.H.; Mucormycosis. Infect Dis Clin North Am 2021,35(1),435-452","journal-title":"Infect Dis Clin North Am"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1469-0691.2009.02984.x","volume":"15","author":"Izquierdo A.C.M.","year":"2009","unstructured":"Izquierdo A.C.M.; Cuesta I.; Zaragoza O.; Monz\u00f3n A.; Mellado E.; In vitro activity of antifungals against Zygomycetes. Clin Microbiol Infect 2009,15(5),71-76","journal-title":"Clin Microbiol Infect"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"13308","DOI":"10.1039\/D0NJ00657B","volume":"44","author":"Balasubramaniyan S.","year":"2020","unstructured":"Balasubramaniyan S.; Irfan N.; Senthilkumar C.; Umamaheswari A.; Puratchikody A.; The synthesis and biological evaluation of virtually designed fluoroquinolone analogs against fluoroquinolone-resistant Escherichia coli intended for UTI treatment. New J Chem 2020,44(31),13308-13318","journal-title":"New J Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1021\/jm401836p","volume":"57","author":"Belema M.","year":"2014","unstructured":"Belema M.; Nguyen V.N.; Bachand C.; Hepatitis C virus NS5A replication complex inhibitors: The discovery of daclatasvir. J Med Chem 2014,57(5),2013-2032","journal-title":"J Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/jof5010026","volume":"5","author":"Prakash H.","year":"2019","unstructured":"Prakash H.; Chakrabarti A.; Global epidemiology of mucormycosis. J Fungi 2019,5(1),26","journal-title":"J Fungi"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/oso\/9780195148091.003.0015","author":"Ibrahim A.S.","year":"2003","unstructured":"Ibrahim A.S.; Edwards J.E.; Filler S.G.; Zygomycosis. Clinical mycology 2003,241-251","journal-title":"Clinical mycology"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jinf.2009.06.002","volume":"59","author":"Ben-Ami R.","year":"2009","unstructured":"Ben-Ami R.; Luna M.; Lewis R.E.; Walsh T.J.; Kontoyiannis D.P.; A clinicopathological study of pulmonary mucormycosis in cancer patients: Extensive angioinvasion but limited inflammatory response. J Infect 2009,59(2),134-138","journal-title":"J Infect"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"102196","DOI":"10.1016\/j.dsx.2021.102196","volume":"15","author":"Mishra Y.","year":"2021","unstructured":"Mishra Y.; Prashar M.; Sharma D.; Akash, Kumar VP, Tilak TVSVGK. Diabetes, COVID 19 and mucormycosis: Clinical spectrum and outcome in a tertiary care medical center in Western India. Diabetes Metab Syndr 2021,15(4),102196","journal-title":"Diabetes Metab Syndr"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"1253e60","DOI":"10.1111\/myc.13353","volume":"64","author":"Selarka L","year":"2021","unstructured":"Selarka L; Sharma S; Saini D; Mucormycosis and COVID-19: An epidemic within a pandemic in India. Mycoses 2021,64(10),1253e60","journal-title":"Mycoses"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1186\/s12879-021-06647-x","volume":"21","author":"Palanisamy N.","year":"2021","unstructured":"Palanisamy N.; Vihari N.; Meena D.S.; Clinical profile of bloodstream infections in COVID-19 patients: A retrospective cohort study. BMC Infect Dis 2021,21(1),933","journal-title":"BMC Infect Dis"},{"key":"ref=25","first-page":"1e16","volume":"19","author":"Muthu V","year":"2021","unstructured":"Muthu V; Rudramurthy SM; Chakrabarti A; Agarwal R; Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world. Mycopathologia 2021,19,1e16","journal-title":"Mycopathologia"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1007\/s12033-021-00358-z","volume":"63","author":"Navabshan I.","year":"2021","unstructured":"Navabshan I.; Sakthivel B.; Pandiyan R.; Computational lock and key and dynamic trajectory analysis of natural biophors against COVID-19 spike protein to identify effective lead molecules. Mol Biotechnol 2021,63(10),898-908","journal-title":"Mol Biotechnol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"3000605211043413","DOI":"10.1177\/03000605211043413","volume":"49","author":"Zia M.","year":"2021","unstructured":"Zia M.; Goli M.; Predisposing factors of important invasive fungal coinfections in COVID-19 patients: A review article. J Int Med Res 2021,49(9),3000605211043413","journal-title":"J Int Med Res"},{"key":"ref=28","unstructured":"WHO. Annex 1: 19th WHO model list of essential medicines 2015. Available from:"}],"container-title":["Current Drug Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2589977515666230430004013","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/216384\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2589977515666230430004013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T08:53:54Z","timestamp":1698828834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/216384\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/2589977515666230430004013","relation":{},"ISSN":["2589-9775"],"issn-type":[{"value":"2589-9775","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-09-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}